NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule
about
NF-κB, the first quarter-century: remarkable progress and outstanding questionsMutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficienciesSynergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradationTax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expressionActivation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expressionHuman cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signalingLoss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation.Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatinRole of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alphaProteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.A requirement for NF-kappaB activation in Bcr-Abl-mediated transformationFunctions of NF-kappaB1 and NF-kappaB2 in immune cell biologyHepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteinsThe human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infectionHuman T-cell leukemia virus type I Tax-protein-mediated activation of NF-kappa B from p100 (NF-kappa B2)-inhibited cytoplasmic reservoirs.The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesisControl of canonical NF-kappaB activation through the NIK-IKK complex pathwayIn vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa BEvidence for the involvement of a nuclear NF-kappa B inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cellsIkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa BReciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription.Reconstitution of the NF-kappa B system in Saccharomyces cerevisiae for isolation of effectors by phenotype modulation.It takes two to tango: IκBs, the multifunctional partners of NF-κB.The complexity of NF-κB signaling in inflammation and cancer.Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-kappaB activation.Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation.Asterias rubens: Evidence of NF-kappa B genes.Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.Expression of constitutively active IkappaB beta in T cells of transgenic mice: persistent NF-kappaB activity is required for T-cell immune responsesRegulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus.
P2860
Q26822516-464AF51D-4281-435B-967F-3C7BA8363665Q28254194-FD731F13-00E3-4B4B-90E6-ADB5FE764971Q28571179-EFC6478E-20B1-4DBE-96CF-6ED67D3DF0D0Q28609394-8F0D1AB7-15C9-4CD4-A808-1790440E18BAQ30453928-FCAE2E01-D868-4CC5-90D8-4086ADA26C03Q33786551-1FE6BA42-2FEE-4E49-B841-545B4B701C3BQ33804558-9C790D54-3F9E-4BAB-94F6-A5DD721BBCCEQ33842473-A8F401AC-CB0E-453C-A38D-FB58C30E8977Q33882384-5ECB33AA-DD9C-406A-95D9-1C62144CEA7FQ33948481-13A42394-56CD-4A70-9CA3-41F3B4D375EDQ34098320-9115171B-242A-45D9-9B4C-2B3D861D2E1AQ34281710-9618C145-26F5-4F43-9EA0-72AF58F63056Q35150453-720A7F83-1093-4A26-A74E-67E24645D859Q35195588-420C393E-19F9-42C5-978E-49929F3B6A97Q35815962-A7CC3AE8-DD38-4E99-A251-513D009E421CQ35864366-C3649D81-C224-4324-B20D-4D8CC6982850Q35887796-EB50DF23-3322-4578-AC06-F39A6FF7531FQ35995731-29F17869-3A20-493E-81FE-0A517427E755Q36371653-0C072846-BECB-4025-8989-ABBF9CF7B59EQ36491362-79E889D4-AF89-49CF-95A4-B223E00D6DBFQ36549755-4F280C05-F04A-4A03-A213-51557FFF10DEQ36556942-06EAB9D3-CC59-47F4-9926-04591AF5335BQ36559410-838A1C14-F856-4BF8-841E-F400F81583F5Q36566875-E976E20A-57C8-4124-AE5B-6931DCADA1D6Q36666605-A660CA4B-C925-4D00-8BA7-7694F9691E95Q36668946-ADDF94F3-79B6-4368-B9F0-F008CFABEA6FQ36673048-36A55DA3-4497-4C17-8CA0-DD8186AE8518Q36867869-A1B52B40-1BF9-4EC3-BB4F-1FD5783CD835Q37995679-DE3A76BA-9002-4F25-8958-AB7DC24DF999Q38126565-45524370-2399-4BDC-9240-6A251B10CBEDQ38182355-0B48C97F-0AAD-429B-AAB9-8BCFA6098E94Q38322425-5CC331D1-7742-442E-A6EA-003C61313829Q38329374-056B5704-A5F9-44B8-9135-1F0829BD717CQ38342766-4AFFDF0B-E472-4704-84AF-CA6CD3B3C20FQ38355384-2E6CCABD-4A55-41BB-93E6-FEF276C28599Q38362646-FEC3032F-1043-47A3-B7CB-F33F8DB9D5D2Q39020393-250AD9F7-3088-4B6B-88D1-6368CEF90091Q39593618-4418D507-B91E-4B2C-86F6-1EF2C319FC33Q39631389-0319188F-06AD-4CC9-A681-E99546AA103EQ39869047-0123BC1B-9ADC-43DF-A11D-EE2ED58FA524
P2860
NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@ast
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@en
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@nl
type
label
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@ast
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@en
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@nl
prefLabel
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@ast
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@en
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@nl
P2093
P2860
P356
P1476
NF-kappa B p100 (Lyt-10) is a ...... as an I kappa B-like molecule
@en
P2093
A S Baldwin
R I Scheinman
P2860
P304
P356
10.1128/MCB.13.10.6089
P407
P577
1993-10-01T00:00:00Z